Treatment of secondary osteosarcoma in a pediatric Hodgkin lymphoma survivor: Overcoming toxicity challenges

Pediatr Blood Cancer. 2021 Dec;68(12):e29269. doi: 10.1002/pbc.29269. Epub 2021 Aug 12.

Authors

Arianexys Aquino-López¹, Lisa L Wang^{1

2}, Ricardo J Flores^{1

2}

Affiliations

¹ Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
² Department of Pediatrics, Section of Hematology Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.

PMID: 34383364
DOI: 10.1002/pbc.29269

No abstract available

Publication types

Letter

MeSH terms

Bone Neoplasms* / drug therapy
Child
Hodgkin Disease* / drug therapy
Humans
Neoplasms, Second Primary*
Osteosarcoma* / drug therapy
Survivors